INTRODUCTION
Anxiety sensitivity is defined as the trait tendency to be fearful of anxiety-related sensations and is also regarded as an important factor closely associated with the experience of pain [1] . More specifically, this unpleasant feeling is commonly referred by patients during the preoperative period making them vulnerable to severe pain following surgery [2] . Patients with greater pain-related anxiety tend to over-estimate the intensity of new onset of pain, thus increasing the likelihood of reported pain [3] [4] [5] [6] [7] . In other words, anxiety sensitivity is not only related to greater pain experience, but it also predisposes patients towards more negative sensations of painful stimuli and, hence, towards a higher intensity of reported pain.
Continuous femoral block affords a commonly performed practice in surgical procedures of total knee arthroplasty (TKA) as an effective means of providing postoperative analgesia, while at the same time it reduces side effects and accelerates functional recovery [8, 9] . Earlier studies highlighted that patients with pain-related anxiety may benefit from sedatives and/or tranquilizers during a painful nerve block procedure [10] [11] [12] [13] , whereas others indicated the potential serious complications that may be caused from the routine use of benzodiazepines, opioids, and ketamine or fentanyl, such as prolonged sedation and amnesic effect after cessation, and hemodynamic instability among others [10, [14] [15] [16] . 
METHODS

Ethics Statement
Informed written consent was given by all the patients prior to enrolment in the study. The study was also reviewed and approved by the Institutional Review Board and the Local Ethics Committee on human research and human studies at Aretaieion University Hospital with reference code S-138/15-06-10, and with the Helsinki Declaration of 1964, as revised in 2013.
Each patient was assigned a code and all data were analyzed anonymously. The randomization process was performed on the morning of surgery, where patients were randomized to one of the two aforementioned groups using computer-generated tables and sealed drawing-coded opaque envelopes. 
Continuous Femoral Nerve Block Under Neurostimulation Guidance
Local anesthesia with lidocaine 1 % (0.5 mg/kg) was used to achieve generous skin and 
Pain and Anxiety Visual Analog Scales
The evening prior to continuous femoral block placement, all patients were introduced to using Patients were asked to circle a number as an answer to each question and the total sum of numbers in each questionnaire was used to compare anxiety levels among patients.
Statistical Analysis
The non-parametric Mann-Whitney test was 
RESULTS
In the current study, a total of 90 patients were randomized to placebo (n = 45) and parecoxib (n = 45). No patient was withdrawn from the study (Fig. 1) . The physical characteristics of the study groups were comparable; most patients were female (83.3 %) and all were Caucasians (100 %). In general, parecoxib provided greater relief than placebo following TKA; data not shown. Anxiety levels in both patient groups are shown in Figs. 2 and 3 . More specifically, anxiety levels of the pre-surgical state (STAI1)
are shown in Fig. 2 , whereas anxiety levels of the post-surgical state (STAI2) are shown in Fig. 3 . Overall, the group receiving parecoxib had lower anxiety levels both pre-and post-surgically, as compared to the placebo group, with statistical significance p = 0.012 and p = 0.002, respectively (Table 1) . Precisely, we demonstrated that 40 mg of intravenous, even pre-emptively administered parecoxib improved the anxiety levels experienced during the perioperative period of TKA.
Consequently, this led to better satisfaction scores and overall experience for the patients, regarding pre-and post-procedural pain, as well as pre-and post-interventional anxiety. Herein, it should be noted that STAI2 afforded the more appropriate tool to evaluate the anxiety levels during the current perioperative period, which undoubtedly can be very stressful for any individual. Nevertheless, we considered the use of STAI1 valuable to extract information about the patient's personality, in general. For example, how patients can cope with stress and anxiety under normal circumstances.
DISCUSSION
The type of anesthesia affords an imperative risk factor for postoperative anxiety and, as it has previously been shown, specifically the neural blockade could effectively protect patients from postoperative anxiety through superior postoperative pain control [2] . In the current study, we have shown that administration of parecoxib had statistically significantly improved anxiety levels for both trait and state anxiety levels, as compared to the placebo. Nevertheless, the evaluation of the state anxiety was the most interesting and relevant to the current study. This difference, however, may not have been directly attributed to parecoxib, at least not post-surgically, as anxiety reduction might have been due to the reduction in procedural pain, i.e., the pain acting as the mediator, and not due to the drug itself. At the same time, since we observed reduced anxiety levels in the pre-surgical state as well, we proposed that the drug exerted a positive anxiolytic influence, whether this was indirectly via reduction of procedural pain, or directly acting on anxiety levels, or both. should be noted that patients were still under parecoxib effect when asked to fill in the questionnaires.
Potential limitations of the current protocol should be also taken into consideration. For instance, one could argue that the anxiety levels measured were indeed associated with the personality characteristics and not the procedure followed, although especially for this reason STAI was the method of choice.
Nonetheless, the current findings are in agreement with our previous study that patients' anxiety levels, experienced prior to an epidural catheter placement [17] .
Collectively, since intravenous infusion of parecoxib has been shown to provide non-steroidal anti-inflammatory drug-mediated central hyperanalgesia, attributed to central COX-2 inhibition [20] , it is possible that it also exerts a positive anxiolytic effect prior to a distressing and painful procedure such as TKA. In addition, taking into account the fact that in anxiety the prefrontal cortex and amygdala, which are involved in analgesia and hyperanalgesia demonstrate concurrent areas of activation in the brain [21] , it was only rational to assume that pre-emptively administered parecoxib was capable of having an anxiolytic effect prior to surgery. Fig. 2 Anxiety levels of the pre-surgical state (STAI1) between the group receiving parecoxib and the group receiving placebo. The group receiving parecoxib has statistically significant lower anxiety levels than the placebo group (p = 0.012) Fig. 3 Anxiety levels of the post-surgical state (STAI2) between the group receiving parecoxib and the group receiving placebo. The group receiving parecoxib has statistically significant lower anxiety levels than the placebo group (p = 0.002) 
